598
Views
70
CrossRef citations to date
0
Altmetric
REVIEWS

Tumoral Angiogenesis: Review of the Literature

&
Pages 104-108 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Joanna A. Niemiec, Agnieszka Adamczyk, Aleksandra Ambicka, Anna Mucha-Małecka, Wojciech M. Wysocki & Janusz Ryś. (2014) Distribution of Podoplanin-Positive Tumor Vessels Predicts Disease-Specific Survival of Node-Positive Breast Cancer Patients Treated with Anthracyclines and/or Taxanes. Cancer Investigation 32:5, pages 168-177.
Read now
Matteo Morotti, Mario Valenzano Menada, Pier Luigi Venturini & Simone Ferrero. (2012) Bevacizumab in endometrial cancer treatment. Expert Opinion on Biological Therapy 12:5, pages 649-658.
Read now
Xinhua Chen, Xinmei Chen, R. James Swanson, Karl H. Schoenbach, Shengyong Yin & Shusen Zheng. (2011) Histopathological follow-up by tissue micro-array in a survival study after melanoma treated by nanosecond pulsed electric fields (nsPEF). Journal of Dermatological Treatment 22:3, pages 153-161.
Read now
Li-ping Liu, Hui-fang Liang, Xiao-ping Chen, Wan-guang Zhang, Sheng-li Yang, Tao Xu & Li Ren. (2010) The Role of NF-κB in Hepatitis B Virus X Protein-Mediated Upregulation of VEGF and MMPs. Cancer Investigation 28:5, pages 443-451.
Read now
David P Samuel, Patrick Y Wen & Mark W Kieran. (2009) Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. Expert Opinion on Investigational Drugs 18:7, pages 973-983.
Read now
Ragini Kudchadkar, Rene Gonzalez & Karl D Lewis. (2008) PI-88: a novel inhibitor of angiogenesis. Expert Opinion on Investigational Drugs 17:11, pages 1769-1776.
Read now

Articles from other publishers (64)

Qingqing He, Yijing He, Changqiang Li, Jianv Wang, Tong Xia, Xia Xiong, Jixiang Xu & Li Liu. (2023) Downregulated BIRC5 inhibits proliferation and metastasis of melanoma through the β-catenin/HIF-1α/VEGF/MMPs pathway. Journal of Cancer Research and Clinical Oncology 149:18, pages 16797-16809.
Crossref
Tae Woo Kim. (2023) Fisetin, an Anti-Inflammatory Agent, Overcomes Radioresistance by Activating the PERK-ATF4-CHOP Axis in Liver Cancer. International Journal of Molecular Sciences 24:10, pages 9076.
Crossref
Xueyan Sun, Yin Zhao, Jingduo Zhao, Zhizhong Xie, Xiaoyong Lei, Xingyun Liu, Yong Li, Sheng Huang, Zhe Wang & Guotao Tang. (2023) Design, synthesis, and antitumor evaluation of trimethoxyflavonoid with arylurea structure against hepatocellular carcinoma. Drug Development Research 84:3, pages 448-464.
Crossref
Mohsin Ahmad Ghauri, Ali Raza, Uzma Hayat, Naveel Atif, Hafiz M.N. Iqbal & Muhammad Bilal. (2022) Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis. Biochimica et Biophysica Acta (BBA) - General Subjects 1866:5, pages 130113.
Crossref
Sophie Bekisz, Louis Baudin, Florence Buntinx, Agnès Noël & Liesbet Geris. (2022) In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies. Cancers 14:6, pages 1525.
Crossref
Melgious Jin Yan Ang, Siew Yin Chan, Yi-Yiing Goh, Zichao Luo, Jun Wei Lau & Xiaogang Liu. (2021) Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics. Advanced Drug Delivery Reviews 178, pages 113907.
Crossref
Elvan ÜSTÜN & Neslihan ŞAHİN. (2021) Analysis of Interactions of NHC Type Molecules and NHC-Ag Complexes with VEGFR-2 and DNA: A Molecular Docking Study. Adıyaman University Journal of Science.
Crossref
Sophie Bekisz & Liesbet Geris. (2020) Cancer modeling: From mechanistic to data-driven approaches, and from fundamental insights to clinical applications. Journal of Computational Science 46, pages 101198.
Crossref
Penelope V. Dalla, Jerran Santos, Bruce K. Milthorpe & Matthew P. Padula. (2020) Selectively-Packaged Proteins in Breast Cancer Extracellular Vesicles Involved in Metastasis. International Journal of Molecular Sciences 21:14, pages 4990.
Crossref
Irshad Ahmad & Muddasarul Hoda. (2020) Attenuation of diabetic retinopathy and neuropathy by resveratrol: Review on its molecular mechanisms of action. Life Sciences 245, pages 117350.
Crossref
Jiating Xu, Arif Gulzar, Dan Yang, Shili Gai, Fei He & Piaoping Yang. (2019) Tumor self-responsive upconversion nanomedicines for theranostic applications. Nanoscale 11:38, pages 17535-17556.
Crossref
Jason H. Gill, Kimberly L. Rockley, Carol De Santis & Asma K. Mohamed. (2019) Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics. Pharmacology & Therapeutics 202, pages 18-31.
Crossref
Oliver Butters, Kate Young, David Cunningham, Ian Chau & Naureen Starling. (2019) Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies. Frontiers in Oncology 9.
Crossref
Ahmed A. Alsultan, Maarten W. Barentsz, Maarten L.J. Smits, Miriam Koopman, Marnix G.E.H. Lam & Charlotte E.N.M. Rosenbaum. (2019) Angiogenesis in 90Y-Radioembolization of Colorectal Liver Metastases. Seminars in Nuclear Medicine 49:3, pages 204-210.
Crossref
Masoumeh Honarmand, Fatemeh Namazi, Ali Mohammadi & Saeed Nazifi. (2018) Can cannabidiol inhibit angiogenesis in colon cancer?. Comparative Clinical Pathology 28:1, pages 165-172.
Crossref
David M. Vail, Douglas H. Thamm & Julias M. Liptak. 2019. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 251 285 .
Maohua Huang, Minfeng Chen, Wencai Ye & Dongmei Zhang. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy 29 43 .
Hossam S. El-Sawy, Ahmed M. Al-Abd, Tarek A. Ahmed, Khalid M. El-Say & Vladimir P. Torchilin. (2018) Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives. ACS Nano 12:11, pages 10636-10664.
Crossref
Fabio Grizzi, Gianluca Basso, Elena Monica Borroni, Tommaso Cavalleri, Paolo Bianchi, Sanja Stifter, Maurizio Chiriva-Internati, Alberto Malesci & Luigi Laghi. (2018) Evolving notions on immune response in colorectal cancer and their implications for biomarker development. Inflammation Research 67:5, pages 375-389.
Crossref
Xiaokun Li. 2018. Fibroblast Growth Factors. Fibroblast Growth Factors 477 558 .
Chenbo Ding, Junmin Luo, Xiaobo Fan, Longmei Li, Shanshan Li, Kunming Wen, Jihong Feng & Guoqiu Wu. (2017) Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Umar Farooq, Sadia Naz, Binte Zehra, Ajmal Khan, Syed Abid Ali, Ayaz Ahmed, Rizwana Sarwar, Syed Majid Bukhari, Abdur Rauf, Izhar Ahmad & Yahia Nasser Mabkhot. (2017) Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway. BMC Cancer 17:1.
Crossref
Koichi Kurishima, Hiroko Watanabe, Hiroichi Ishikawa, Hiroaki Satoh & Nobuyuki Hizawa. (2017) A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer. Molecular and Clinical Oncology 7:1, pages 131-134.
Crossref
Elif Birtas Atesoglu, Pinar Tarkun, Ozgur Mehtap, Esra Terzi Demirsoy, Figen Atalay, Muhammet Maden, Koray Celebi & Abdullah Hacihanefioglu. (2015) Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis. Indian Journal of Hematology and Blood Transfusion 32:2, pages 162-167.
Crossref
Kamran Mansouri, Ali Mostafie, Davood Rezazadeh, Mohsen Shahlaei & Mohammad Hossein Modarressi. (2016) New function of TSGA10 gene in angiogenesis and tumor metastasis: a response to a challengeable paradox . Human Molecular Genetics 25:2, pages 233-244.
Crossref
Edward M. BarksdaleJr.Jr. & Iuliana D. Bobanga. 2016. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors 681 710 .
Shibin Feng, Lingyun Zou, Qingshan Ni, Xiang Zhang, Qianwei Li, Lei Zheng, Laiping Xie, Hongmin Li & Dingde Huang. (2014) Modulation, Bioinformatic Screening, and Assessment of Small Molecular Peptides Targeting the Vascular Endothelial Growth Factor Receptor. Cell Biochemistry and Biophysics 70:3, pages 1913-1921.
Crossref
Salida Mirzoeva, Carrie A. Franzen & Jill C. Pelling. (2014) Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. Molecular Carcinogenesis 53:8, pages 598-609.
Crossref
Yuan Wu, Wei-li Sun & Ji-feng Feng. (2013) Antiangiogenic therapy in the management of breast cancer. Asia-Pacific Journal of Clinical Oncology 9:2, pages 110-116.
Crossref
. 2013. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 215 244 .
I. Alkatout, N. Maass, W. Jonat, C. Mundhenke & C. Schem. (2012) Rolle der Angiogenese und ihrer Inhibitoren in der GynäkologieThe role of angiogenesis and its inhibitors in gynecology. Der Gynäkologe 46:1, pages 56-62.
Crossref
Pravin TP KaumayaKevin Chu Foy. (2012) Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy. Future Oncology 8:8, pages 961-987.
Crossref
Asmae Karroum, Pezhman Mirshahi, Anne-Marie Faussat, Amu Therwath, Massoud Mirshahi & Mohamed Hatmi. (2012) Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions. European Journal of Pharmacology 685:1-3, pages 1-7.
Crossref
Hiroshi Matono, Sadafumi Tamiya, Ryohei Yokoyama, Tsuyoshi Saito, Yukihide Iwamoto, Masazumi Tsuneyoshi & Yoshinao Oda. (2011) Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression. Histopathology 59:3, pages 368-375.
Crossref
Elisabeth I. Heath, George R. BlumenscheinJrJr, Roger B. Cohen, Patricia M. LoRusso, Noelle K. LoConte, Sindy T. Kim, Ana Ruiz-Garcia, Richard C. Chao & George Wilding. (2010) Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results. Cancer Chemotherapy and Pharmacology 68:3, pages 703-712.
Crossref
Ramaswamy Bhuvaneswari, Gan Yik Yuen, Soo Khee Chee & Malini Olivo. (2011) Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. Lasers in Surgery and Medicine 43:7, pages 651-662.
Crossref
Junjie Yao & Lihong V. Wang. (2011) Photoacoustic tomography: fundamentals, advances and prospects. Contrast Media & Molecular Imaging 6:5, pages 332-345.
Crossref
Yuan Wu, Weili Sun & Jifeng Feng. (2011) Antiangiogenic therapy for breast cancer: current status and future perspectives. The Chinese-German Journal of Clinical Oncology 10:7, pages 373-379.
Crossref
Wenxing Chen, Yin Lu, Jiaming Wu, Ming Gao, Aiyun Wang & Bo Xu. (2010) Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemotherapy and Pharmacology 67:4, pages 799-808.
Crossref
Ching‐Shu Lai, Mei‐Ling Tsai, An‐Chin Cheng, Shiming Li, Chih‐Yu Lo, Yu Wang, Hang Xiao, Chi‐Tang Ho, Ying‐Jan Wang & Min‐Hsiung Pan. (2010) Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane‐treated mice. Molecular Nutrition & Food Research 55:2, pages 278-290.
Crossref
Xijian Zhou, Jun Yang, Jinying Liang, Peng Li, Yuquan Wu, Xiaoqiang Fan & Xiangyong Li. (2011) Clinical Analysis of Bevacizumab Plus FOLFIRI Regimen as Front-Line Therapy for Chinese Patients with Advanced Colorectal Cancer. Journal of Cancer Therapy 02:04, pages 470-474.
Crossref
Eun Su Jeon, Il Hwan Lee, Soon Chul Heo, Sang Hun Shin, Yoon Ji Choi, Ji Hye Park, Do Youn Park & Jae Ho Kim. (2010) Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1801:11, pages 1205-1213.
Crossref
Asmae Karroum, Pezhman Mirshahi, Nadia Benabbou, Anne-Marie Faussat, Jeannette Soria, Amu Therwath, Massoud Mirshahi & Mohamed Hatmi. (2010) Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Letters 295:2, pages 242-251.
Crossref
Ming Liu, Rui-Hai Liu, Bing-Bing Song, Chun-Feng Li, Luo-Qiang Lin, Chun-Peng Zhang, Jin-Lu Zhao & Jia-Ren Liu. (2010) Antiangiogenetic Effects of 4 Varieties of Grapes In Vitro. Journal of Food Science 75:6, pages T99-T104.
Crossref
Jennifer R. Choo & Torsten O. Nielsen. (2010) Biomarkers for Basal-like Breast Cancer. Cancers 2:2, pages 1040-1065.
Crossref
Rakesh K. Srivastava, Terry G. Unterman & Sharmila Shankar. (2009) FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Molecular and Cellular Biochemistry 337:1-2, pages 201-212.
Crossref
De-Hong Yu, Qin Lu, Jing Xie, Chao Fang & Hong-Zhuan Chen. (2010) Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials 31:8, pages 2278-2292.
Crossref
Ivan Carlos Santos, Vivian Nogueira Silbiger, Débora Ayame Higuchi, Maria Aparecida Gomes, Lucíola Silva Barcelos, Mauro Martins Teixeira, Mirian Teresa Paz Lopes, Valbert Nascimento Cardoso, Mercia Paula Lima, Ronaldo Carvalho Araujo, João Bosco Pesquero & Jorge Luiz Pesquero. (2010) Angiostatic activity of human plasminogen fragments is highly dependent on glycosylation. Cancer Science 101:2, pages 453-459.
Crossref
Xiaoping Wu, Qiuxia Yan, Yadong Huang, Huixian Huang, Zhijian Su, Jian Xiao, Yaoying Zeng, Yi Wang, Changjun Nie, Yongguang Yang & Xiaokun Li. (2010) Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity. Journal of Cellular and Molecular Medicine 14:1-2, pages 351-356.
Crossref
Carlos A Castaneda & Henry L Gomez. (2009) Pazopanib: an antiangiogenic drug in perspective. Future Oncology 5:9, pages 1335-1348.
Crossref
Noboru Yamamoto, Tomohide Tamura, Nobuyuki Yamamoto, Kazuhiko Yamada, Yasuhide Yamada, Hiroshi Nokihara, Yutaka Fujiwara, Toshiaki Takahashi, Haruyasu Murakami, Narikazu Boku, Kentaro Yamazaki, Thomas A. Puchalski & Eisei Shin. (2009) Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology 64:6, pages 1165-1172.
Crossref
Matthias Glaser, Magne Solbakken, David R. Turton, Roger Pettitt, Jon Barnett, Joseph Arukwe, Hege Karlsen, Alan Cuthbertson, Sajinder K. Luthra & Erik Årstad. (2008) Methods for 18F-labeling of RGD peptides: comparison of aminooxy [18F]fluorobenzaldehyde condensation with ‘click labeling’ using 2-[18F]fluoroethylazide, and S-alkylation with [18F]fluoropropanethiol. Amino Acids 37:4, pages 717-724.
Crossref
Jean-Louis FormentoMarie-Christine Etienne-GrimaldiMireille FrancoualGilles PagèsCercina OnestoPatricia FormentoEmmanuel ChamoreyOlivier DassonvilleGilles PoissonnetGérard Milano. (2009) Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer . Pharmacogenomics 10:8, pages 1277-1283.
Crossref
Stuart A. Taylor, Shonit Punwani, Manuel Rodriguez-Justo, Alan Bainbridge, Rebecca Greenhalgh, Enrico De Vita, Alastair Forbes, Richard Cohen, Alastair Windsor, Austin Obichere, Anika Hansmann, Janaki Rajan, Marco Novelli & Steve Halligan. (2009) Mural Crohn Disease: Correlation of Dynamic Contrast-enhanced MR Imaging Findings with Angiogenesis and Inflammation at Histologic Examination—Pilot Study. Radiology 251:2, pages 369-379.
Crossref
Ricardo Lima Barros Costa. (2009) Review Article: Targeted Therapy: Comprehensive Review. American Journal of Hospice and Palliative Medicine® 26:2, pages 137-146.
Crossref
G J Dougherty & S T Dougherty. (2008) Exploiting the tumor microenvironment in the development of targeted cancer gene therapy. Cancer Gene Therapy 16:3, pages 279-290.
Crossref
Parham Khosravi Shahi, Alicia Soria Lovelle & Gumersindo Pérez Manga. (2009) Tumoral angiogenesis and breast cancer. Clinical and Translational Oncology 11:3, pages 138-142.
Crossref
Kar Wah Leung, Fung Ping Leung, Nai Ki Mak, Joyce Tombran-Tink, Yu Huang & Ricky NS Wong. (2009) Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells. British Journal of Pharmacology 156:4, pages 626-637.
Crossref
Sarah Koenig, Petra Krause, Ali Seif Amir Hosseini, Christian Dullin, Margret Rave-Fraenk, Sarah Kimmina, Andrew Lee Entwistle, Robert Michael Hermann, Clemens Friedrich Hess, Heinz Becker & Hans Christiansen. (2009) Noninvasive Imaging of Liver Repopulation following Hepatocyte Transplantation. Cell Transplantation 18:1, pages 69-78.
Crossref
Rana P. Singh, Komal Raina, Girish Sharma & Rajesh Agarwal. (2008) Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice. Clinical Cancer Research 14:23, pages 7773-7780.
Crossref
Haoying Yu, Robert M. Straubinger, Jin Cao, Hao Wang & Jun Qu. (2008) Ultra-sensitive quantification of paclitaxel using selective solid-phase extraction in conjunction with reversed-phase capillary liquid chromatography/tandem mass spectrometry. Journal of Chromatography A 1210:2, pages 160-167.
Crossref
Davoud AhmadvandMohammad J. RasaeeFatemeh RahbarizadehMohammad Mohammadi. (2008) Production and Characterization of a High-Affinity Nanobody Against Human Endoglin. Hybridoma 27:5, pages 353-360.
Crossref
Kevin J. Freise, Robert L. Schmidt, John A. Widness & Peter Veng-Pedersen. (2008) Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response. Journal of Pharmacokinetics and Pharmacodynamics 35:5, pages 527-552.
Crossref
Mohanraj Dhanabal, S. Ananth Karumanchi & Vikas P. Sukhatme. (2008) Targeting tumor vascular endothelium: an emerging concept for cancer therapy. Drug Development Research 69:6, pages 340-351.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.